Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9721 - 9728 of 11616 results
Credit Where Credit Is Due: Renewable Thermal Energy Heats Up
September 17, 2014| Article| Viewpoint
D.C. the Latest Jurisdiction to Ban the Box
September 17, 2014| Blog| Viewpoint
Employment Law Summer Recap 2014: Part 3 of 11 - The Decision 2.0: This Time, LeBron Leaves the Right Way; Will Your Employees?
September 17, 2014| Blog| Viewpoint
California Employers May Get Ill Over California’s New Mandatory Paid Sick Leave Law
September 17, 2014| Blog| Viewpoint
BREAKING NEWS: THE COPPA ENFORCEMENT ACTIONS ARE HERE!
September 17, 2014| Blog| Viewpoint
NIST Vetting Guidance Valuable for Health Care Organizations Seeking to Use Third-Party Apps
September 17, 2014| Blog| Viewpoint
Do Not Pass Go: Federal Judge Orders Execs Jailed for Contempt of Recall Order
September 16, 2014| Blog| Viewpoint
What 2014’s Continued IPO Surge Means for Clean Tech and Renewable Energy Companies
September 16, 2014| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.